AIF is the investment and innovation arm for ASD and related conditions.
Meet our portfolio companies >>

Cision PRWeb / April 20, 2022
AIF Makes Strategic Investment in Cortica
NYSE / April 19, 2022
AIF Rings Closing Bell at New York
Stock Exchange
Latest news
Seed, 2021

diagnosis for
neurodevelopmental
disorders is achievable
with a simple blood test.
AIF is building a world where
AIF is the investment and innovation arm for ASD and related conditions.
Meet our portfolio companies >>

Cision PRWeb / April 20, 2022
AIF makes strategic investment in Cortica...
NYSE / April 19, 2022
AIF rings closing bell at NYSE...
Latest news
Seed, 2021
diagnosis for neurodevelopmental disorders is achievable with a simple blood test
AIF is building a world where

OUR MISSION
AIF’s bold mission is to revolutionize the status quo for diagnosing, treating, and living with autism spectrum disorder (ASD), neurodevelopmental disorders, mental health issues, and complex chronic conditions through a venture capital model that helps accelerate developing and delivering emerging technologies, translational science, and innovative services to empower individuals to reach their full potential.
OUR VISION
We identify unmet needs across the continuum of ASD and related conditions and deploy venture capital to invent, develop, and fuel solutions that address those needs.
AS FEATURED ON





